A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
Aaron Mertens
Advertisement
Aaron Mertens is a Microbiologist and Technical Services Manager at STERIS Life Sciences.
Articles by Aaron Mertens
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5